The DNA/ChAd63 vaccine induced superior protection in humans using the three-antigen combination CSP, AMA1 and TRAP compared to the earlier DNA prime-recombinant viral boost malaria vaccine containing only CSP and AMA1. The gene discussed is DNAJC5; the disease is malaria.